In a new study, women with relatively small, HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted therapy following surgery or radiation therapy were very unlikely to have the cancer recur within a few years of treatment, investigators at Dana-Farber Cancer Institute and other research centers will report at the 2013 San Antonio Breast Cancer Symposium.
– Dana-Farber Cancer Institute|12/11/2013 8:30 AM EST
Next to colorectal cancer, endometrial cancer is the most common form of cancer in women with Lynch syndrome. Mounting evidence suggests routine Lynch syndrome testing be done on every endometrial cancer specimen. Raising awareness of endometrial cancer’s association with Lynch syndrome will identify more treatable cancers.
– Norris Cotton Cancer CenterDartmouth-Hitchcock Medical Center|12/11/2013 8:00 AM EST
Findings from a new global study suggest that estimates of gender-based violence (GBV) prevalence based on health systems data or on police reports may underestimate the actual total prevalence by 11- to 128-fold.
– Stony Brook Medicine|12/10/2013 4:00 PM EST
A first-of-its-kind clinical trial studying two forms of stem cell treatments for children with cerebral palsy (CP) has begun at The University of Texas Health Science Center at Houston (UTHealth) Medical School.
– University of Texas Health Science Center at Houston|12/10/2013 4:00 PM EST
Researchers at the Duke Cancer Institute have found that a byproduct of cholesterol functions like the hormone estrogen, fueling the growth and spread of the most common types of breast cancers.
– Newswise|12/10/2013 3:40 PM EST
Combat-Related Injuries Leave Their Mark: Researchers Find Brain Imaging Differences in Veterans with TBI, Years Later
A recent study used diffusion tensor imaging, a type of highly sensitive magnetic resonance image (MRI), to examine the way water moves throughout the brain’s white matter.
– Saint Louis University Medical Center|12/10/2013 3:05 PM EST
Scientists at the Koch Institute for Integrated Cancer Research at MIT are researching how shifts in zinc’s location could be exploited for early diagnosis of prostate cancer.
– Koch Institute for Integrative Cancer Research at MIT|12/10/2013 3:00 PM EST
A drug now used to treat a type of lymphoma has shown surprising benefit in preclinical studies of inflammatory breast cancer
– Thomas Jefferson University|12/10/2013 3:00 PM EST
Cancer News Source is a joint project by Newswise and the National Cancer Institute to promote cancer research news to the public and news media.
Newswise is where journalists choose, connect, and use smart news.
Journalists use Newswise as a source for news leads and experts from the world’s leading organizations. Members of the media can get a PressPass for access to privileged Embargoed News and expert contact information.
Newswise members use Newswise to reach the media with their news releases through our website and email wires. Members are innovative, influential organizations world-wide, including top medical schools, universities, research institutions, public relations firms, government agencies, non-profit organizations, associations and advocacy groups.
Anyone interested in knowledge-based news can register for Newswise and subscribe to the email wires.